Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • CD38 as a therapeutic target f...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
CD38 as a therapeutic target for adult acute myeloid leukemia and T-cell acute lymphoblastic leukemia

CD38 as a therapeutic target for adult acute myeloid leukemia and T-cell acute lymphoblastic leukemia

Bibliographic Details
Main Authors: Jyoti Naik, Maria Themeli, Regina de Jong-Korlaar, Ruud W.J. Ruiter, Pino J Poddighe, Huipin Yuan, Joost D. de Bruijn, Gert J. Ossenkoppele, Sonja Zweegman, Linda Smit, Tuna Mutis, Anton C.M. Martens, Niels W.C.J. van de Donk, Richard W.J. Groen
Format: Article
Language:English
Published: Ferrata Storti Foundation 2019-03-01
Series:Haematologica
Online Access:https://haematologica.org/article/view/8821
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://haematologica.org/article/view/8821

Similar Items

  • Preclinical evidence for an effective therapeutic activity of FL118, a novel survivin inhibitor, in patients with relapsed/refractory multiple myeloma
    by: Lisa C. Holthof, et al.
    Published: (2020-02-01)
  • CD38-specific Chimeric Antigen Receptor Expressing Natural Killer KHYG-1 Cells: A Proof of Concept for an “Off the Shelf” Therapy for Multiple Myeloma
    by: Arwen Stikvoort, et al.
    Published: (2021-07-01)
  • Pre-clinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of multiple myeloma
    by: Esther Drent, et al.
    Published: (2016-05-01)
  • Acute myeloid leukemia
    by: Gert Ossenkoppele
    Published: (2018-06-01)
  • CD38 knockout natural killer cells expressing an affinity optimized CD38 chimeric antigen receptor successfully target acute myeloid leukemia with reduced effector cell fratricide
    by: Mark Gurney, et al.
    Published: (2020-12-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs